- Home
- OCS vs CLOV Comparison
OCS vs CLOV Comparison
Compare OCS & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OCS | CLOV |
|---|---|---|
| Founded | 2003 | 2014 |
| Country | Switzerland | United States |
| Employees | 60 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | OCS | CLOV |
|---|---|---|
| Price | $11.93 | $4.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $42.00 | $2.90 |
| AVG Volume (30 Days) | 473.1K | ★ 6.9M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.03 |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $1,924,308,000.00 |
| Revenue This Year | $466.06 | $52.59 |
| Revenue Next Year | $479.73 | $15.37 |
| P/E Ratio | ★ N/A | $90.00 |
| Revenue Growth | N/A | ★ 40.34 |
| 52 Week Low | $10.52 | $1.58 |
| 52 Week High | $34.48 | $5.59 |
Technical Indicators
Market Signals| Indicator | OCS | CLOV |
|---|---|---|
| Relative Strength Index (RSI) | 33.01 | 53.27 |
| Support Level | $10.52 | $1.96 |
| Resistance Level | $21.82 | $5.18 |
| Average True Range (ATR) | 0.72 | 0.29 |
| MACD | 0.19 | -0.09 |
| Stochastic Oscillator | 7.14 | 39.18 |
Price Performance
Historical ComparisonAbout OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.